Pursley James sold $2.3M of HNGE
Pursley James (President) sold 33,000 shares of Hinge Health, Inc. (HNGE) at an average of $69.31 ($68.93–$70.89, $2.29M total) across 3 trades on 2026-06-22 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider ownership and may marginally influence sentiment, but it does not change company fundamentals in the text provided.
Market read
A scheduled insider sale of ~$2.29M worth of HNGE shares was filed, offering limited incremental trading signal.
What to watch
Traders may want to compare with prior insider activity cadence and whether other executives also sell around the same window.
Background
The article is an SEC Form 4 insider transaction disclosure for Hinge Health, Inc.
Ticker impact
Form 4 shows President Pursley James sold 33,000 HNGE shares in open-market trades under a 10b5-1 plan on 2026-06-22.
Likely minimal price impact; any effect is short-lived unless follow-on insider selling appears.
The filing is a disclosed insider transaction with pre-arranged 10b5-1 structure; it is not a new operational or financial catalyst.
Market effects
No sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled diversification rather than bearish fundamentals.
Key entities
- issuerHinge Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderPursley James
President and reporting insider who sold shares.
- trading mechanism10b5-1 plan
Pre-arranged plan cited as the basis for the sale.